Regulation of CXCR/IL-8 in Human Airway Epithelial Cells

Background: Severe asthma is characterized by neutrophilic inflammation and high levels of interleukin (IL)-8. Airway epithelial cells play a pivotal role in the pathogenesis and chronicity of asthma. The objective of this work was to determine whether CXC receptors were involved in human small airway epithelial cell (SAEC) activity by incubating them with IL-8; the investigation also included a proteomic approach. Methods: IL-6 and intercellular adhesion molecule-1 (ICAM-1) were assessed by ELISA and flow cytometry, respectively. CXCR-1 and CXCR-2 receptor mRNA and protein expressions were analyzed by RT-PCR, immunocytochemistry and flow cytometry. Cells were incubated with different concentrations (0–100 ng/ml) of IL-8. The involvement of both receptors was assessed using specific antibodies. Results: Only the CXCR-1 receptor was expressed in SAECs. IL-8 (50 ng/ml, 12 h) induced the release of IL-6 and had no effect on ICAM-1. Supernatants analyzed by surface enhanced laser desorption ionization time of flight mass spectrometry (SELDI-TOF MS) showed very weak differences in peptide profiles. Interestingly, 4,820-m/z peptide release was detected in the presence of IL-8 and abolished by CXCR-1 antibody. Discussion: The present study illustrated the fact that IL-8 mediated by CXCR-1 increased IL-6. We also highlight the usefulness of SELDI ProteinChip technology to confirm the potential variation of peptide profile. Moreover, we were able to detect the 4,820-m/z peptide secreted in vitro by human airway epithelial cells induced by IL-8 via CXCR-1 receptor. Determination of the protein secretion profile in response to inflammatory stimuli could be an important therapeutic strategy in severe asthma.

[1]  D. Gingras,et al.  Membrane-Type 1 Matrix Metalloproteinase Stimulates Cell Migration through Epidermal Growth Factor Receptor Transactivation , 2007, Molecular Cancer Research.

[2]  K. Rabe,et al.  Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation. , 2007, Lung cancer.

[3]  R. Ravazzolo,et al.  Proteomic analysis of the airway surface liquid: modulation by proinflammatory cytokines. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[4]  F. Luppia,et al.  Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation , 2007 .

[5]  P. Munson,et al.  Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage , 2006, Proteomics.

[6]  L. Farkas,et al.  Expression of CXC chemokine receptors 1 and 2 in human bronchial epithelial cells. , 2005, Chest.

[7]  N. Makeeva,et al.  Effect of cytokines on ICAM‐1 and ZO‐1 expression on human airway epithelial cells , 2005, Cell biology international.

[8]  M. Lenter,et al.  Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface‐enhanced laser desorption/ionization‐mass spectrometry profiling with mass spectrometric protein identification , 2005, Proteomics.

[9]  P. Chanez.  Severe asthma is an epithelial disease , 2005, European Respiratory Journal.

[10]  Y. Saeki,et al.  Protective effect of IL-6 on alveolar epithelial cell death induced by hydrogen peroxide. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[11]  W. D. Boer.  Perspectives for cytokine antagonist therapy in COPD. , 2005 .

[12]  B. Wiedenmann,et al.  CXCL8 modulates human intestinal epithelial cells through a CXCR1 dependent pathway. , 2004, Cytokine.

[13]  J. Bousquet,et al.  Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound. , 2005, The Journal of allergy and clinical immunology.

[14]  B. Balbi,et al.  Downmodulation of CXCL8/IL-8 receptors on neutrophils after recruitment in the airways. , 2005, The Journal of allergy and clinical immunology.

[15]  W. D. de Boer,et al.  Perspectives for cytokine antagonist therapy in COPD. , 2005, Drug discovery today.

[16]  Emanuel F Petricoin,et al.  Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml. , 2004, The Journal of urology.

[17]  J. Lapidus,et al.  Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. , 2004, JAMA.

[18]  Timothy Planche,et al.  A novel and accurate diagnostic test for human African trypanosomiasis , 2004, The Lancet.

[19]  D. Hochstrasser,et al.  A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease , 2003, Proteomics.

[20]  Thomas P Conrads,et al.  SELDI-TOF MS for diagnostic proteomics. , 2003, Analytical chemistry.

[21]  Carl Nathan,et al.  Points of control in inflammation , 2002, Nature.

[22]  Cong Yan,et al.  Transcriptional Stimulation of the Surfactant Protein B Gene by STAT3 in Respiratory Epithelial Cells* , 2002, The Journal of Biological Chemistry.

[23]  J. Bousquet,et al.  Modulation of cadherin and catenins expression by tumor necrosis factor-alpha and dexamethasone in human bronchial epithelial cells. , 2002, American journal of respiratory cell and molecular biology.

[24]  J. Kips,et al.  Cytokines in asthma , 2001, European Respiratory Journal.

[25]  P. Gibson,et al.  Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8. , 2001, Chest.

[26]  R. Homer,et al.  Interleukin-6-induced protection in hyperoxic acute lung injury. , 2000, American journal of respiratory cell and molecular biology.

[27]  C. Dinney,et al.  Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  K. Chung,et al.  Neutrophilic inflammation in severe persistent asthma. , 1999, American journal of respiratory and critical care medicine.

[29]  S. Wenzel,et al.  Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. , 1999, American journal of respiratory and critical care medicine.

[30]  J. Bousquet,et al.  Glucocorticoid receptors in bronchial epithelial cells in asthma. , 1998, American journal of respiratory and critical care medicine.

[31]  R. Djukanović,et al.  The role of ICAM-1 on T-cells in the pathogenesis of asthma. , 1998, The European respiratory journal.

[32]  M. Jordana,et al.  IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. , 1998, The Journal of clinical investigation.

[33]  R. Djukanović,et al.  Free and complexed interleukin-8 in blood and bronchial mucosa in asthma. , 1997, American journal of respiratory and critical care medicine.

[34]  P. Murphy,et al.  The CXC Chemokines Growth-regulated Oncogene (GRO) α, GROβ, GROγ, Neutrophil-activating Peptide-2, and Epithelial Cell-derived Neutrophil-activating Peptide-78 Are Potent Agonists for the Type B, but Not the Type A, Human Interleukin-8 Receptor* , 1996, The Journal of Biological Chemistry.

[35]  J. Bousquet,et al.  Interleukin 8 in bronchoalveolar lavage of asthmatic and chronic bronchitis patients. , 1996, International archives of allergy and immunology.

[36]  S. Dubinett,et al.  Interleukin-8 inhibits non-small cell lung cancer proliferation: a possible role for regulation of tumor growth by autocrine and paracrine pathways. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[37]  Kwang Woo Kim,et al.  Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. , 1995, The Journal of allergy and clinical immunology.

[38]  J. Robotham,et al.  The acute-phase response. , 1995, New horizons.

[39]  J. Gauldie,et al.  The acute phase response. , 1994, Immunology today.

[40]  H. Tilg,et al.  Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. , 1994, Blood.

[41]  K. Ohta,et al.  Growth inhibition of human lung cancer cell lines by interleukin 6 in vitro: a possible role in tumor growth via an autocrine mechanism. , 1993, Cancer research.

[42]  J. Bousquet,et al.  HLA-DR and ICAM-1 expression on bronchial epithelial cells in asthma and chronic bronchitis. , 1993, The American review of respiratory disease.

[43]  J. Mckillop,et al.  Interleukin 8. , 1993, Autoimmunity.

[44]  S. Mattoli,et al.  Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. , 1992, The Journal of allergy and clinical immunology.

[45]  W I Wood,et al.  Structure and functional expression of a human interleukin-8 receptor. , 1991, Science.

[46]  T. Standiford,et al.  Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. , 1991, Experimental lung research.